OFCM
FPRX

One Fin Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

One Fin Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-440,000
Closed -$16.6M – 32
2021
Q1 		$16.6M Buy
+440,000
New +$11M 6.37% 4

One Fin Capital Management's FPRX Position: Q2 2021 in Review

One Fin Capital Management sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 440,000 shares — an estimated $16.6M sold.

One Fin Capital Management first reported a position in FPRX in Q1 2021 and held it in 1 quarter. The position peaked at $16.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.

  • One Fin Capital Management reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
  • One Fin Capital Management sold 440,000 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $16.6M.
  • One Fin Capital Management first reported a position in Five Prime Therapeutics, Inc. in Q1 2021 and held it in 1 quarter.
  • One Fin Capital Management's Five Prime Therapeutics, Inc. position peaked at $16.6M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.

Based on One Fin Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.